Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Larimar Therapeutics, Inc.

NASDAQ: LRMR · Life Sciences · 10 alerts · CIK 1374690

Share price
$3.00Close, Nov 16
Market cap
$314M
Shares outstanding
104.63MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Larimar Therapeutics, Inc. filings on SEC EDGAR ↗

4:10 PM ET 8-K
Business Update

Larimar Therapeutics Business Update

Larimar Therapeutics has completed its rolling Biologics License Application (BLA) submission to the FDA seeking accelerated approval for nomlabofusp in Friedreich’s ataxia. The filing also includes a preliminary cash balance of $128.7 million as of September 30, 2026, and an updated corporate presentation for investor meetings.

Counterparty
FDA

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.